TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation August 29, 2014